Magnesium oxide-pyridoxine therapy for recurrent urolithiasis.
D000818:Animals; D002130:Calcium Phosphates / Q000378:metabolism; D006801:Humans; D008275:Magnesium Deficiency / Q000150:complications; D008277:Magnesium Oxide / Q000627:therapeutic use*; D008297:Male; D010070:Oxalates / Q000378:metabolism; D011736:Pyridoxine / Q000627:therapeutic use*; D014545:Urinary Calculi / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control; D026681:Vitamin B 6 Deficiency / Q000150:complications
D002130:Calcium Phosphates; D010070:Oxalates; D008277:Magnesium Oxide; D011736:Pyridoxine